Gofen & Glossberg’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $858K | Buy |
2,970
+74
| +3% | +$22.6K | 0.02% | 262 |
|
|
2022
Q3 | $839K | Buy |
2,896
+8
| +0.3% | +$2.3K | 0.02% | 245 |
|
|
2022
Q2 | $814K | Sell |
2,888
-206
| -7% | -$55.1K | 0.02% | 252 |
|
|
2022
Q1 | $807K | Hold |
3,094
| – | – | 0.02% | 262 |
|
|
2021
Q4 | $679K | Sell |
3,094
-31
| -1% | -$6.03K | 0.01% | 301 |
|
|
2021
Q3 | $567K | Buy |
3,125
+31
| +1% | +$6.05K | 0.01% | 320 |
|
|
2021
Q2 | $624K | Sell |
3,094
-326
| -10% | -$68.2K | 0.01% | 302 |
|
|
2021
Q1 | $735K | Sell |
3,420
-35
| -1% | -$7.69K | 0.02% | 273 |
|
|
2020
Q4 | $817K | Sell |
3,455
-42
| -1% | -$9.64K | 0.02% | 252 |
|
|
2020
Q3 | $952K | Buy |
3,497
+206
| +6% | +$56.8K | 0.03% | 224 |
|
|
2020
Q2 | $955K | Hold |
3,291
| – | – | 0.03% | 214 |
|
|
2020
Q1 | $783K | Buy |
3,291
+13
| +0.4% | +$2.98K | 0.03% | 215 |
|
|
2019
Q4 | $718K | Sell |
3,278
-74
| -2% | -$15K | 0.02% | 249 |
|
|
2019
Q3 | $568K | Buy |
3,352
+42
| +1% | +$7.43K | 0.02% | 272 |
|
|
2019
Q2 | $607K | Hold |
3,310
| – | – | 0.02% | 261 |
|
|
2019
Q1 | $609K | Hold |
3,310
| – | – | 0.02% | 249 |
|
|
2018
Q4 | $549K | Hold |
3,310
| – | – | 0.02% | 251 |
|
|
2018
Q3 | $638K | Hold |
3,310
| – | – | 0.02% | 252 |
|
|
2018
Q2 | $563K | Hold |
3,310
| – | – | 0.02% | 261 |
|
|
2018
Q1 | $539K | Hold |
3,310
| – | – | 0.02% | 269 |
|
|
2017
Q4 | $496K | Hold |
3,310
| – | – | 0.02% | 299 |
|
|
2017
Q3 | $503K | Hold |
3,310
| – | – | 0.02% | 288 |
|
|
2017
Q2 | $427K | Sell |
3,310
-50
| -1% | -$6.02K | 0.02% | 313 |
|
|
2017
Q1 | $367K | Sell |
3,360
-39
| -1% | -$3.43K | 0.01% | 335 |
|
|
2016
Q4 | $250K | Hold |
3,399
| – | – | 0.01% | 378 |
|
|
2016
Q3 | $296K | Hold |
3,399
| – | – | 0.01% | 353 |
|
|
2016
Q2 | $292K | Sell |
3,399
-202
| -6% | -$17.5K | 0.01% | 356 |
|
|
2016
Q1 | $286K | Buy |
3,601
+91
| +3% | +$8.23K | 0.01% | 357 |
|
|
2015
Q4 | $442K | Buy |
3,510
+300
| +9% | +$36.2K | 0.02% | 290 |
|
|
2015
Q3 | $334K | Buy |
3,210
+25
| +0.8% | +$3.21K | 0.02% | 322 |
|
|
2015
Q2 | $393K | Hold |
3,185
| – | – | 0.02% | 309 |
|
|
2015
Q1 | $376K | Hold |
3,185
| – | – | 0.02% | 319 |
|
|
2014
Q4 | $378K | Buy |
3,185
+35
| +1% | +$3.94K | 0.02% | 315 |
|
|
2014
Q3 | $354K | Hold |
3,150
| – | – | 0.02% | 315 |
|
|
2014
Q2 | $298K | Sell |
3,150
-950
| -23% | -$66.6K | 0.01% | 347 |
|
|
2014
Q1 | $332K | Hold |
4,100
| – | – | 0.02% | 324 |
|
|
2013
Q4 | $305K | Sell |
4,100
-200
| -5% | -$13.9K | 0.01% | 335 |
|
|
2013
Q3 | $326K | Hold |
4,300
| – | – | 0.02% | 309 |
|
|
2013
Q2 | $344K | Buy |
+4,300
| New | +$317K | 0.02% | 290 |
|
Other funds holding VRTX
Gofen & Glossberg's VRTX Position: Q4 2022 in Review
Gofen & Glossberg increased its Vertex Pharmaceuticals (VRTX) stake by 2.6% in Q4 2022, buying an estimated $22.6K and bringing the position to 2,970 shares worth $858K. The position accounts for 0.02% of the portfolio, ranked #262.
Gofen & Glossberg first reported a position in VRTX in Q2 2013 and has held it in 39 quarters since. The position peaked at $955K in Q2 2020. 1,223 funds tracked by Wall St. Rank hold VRTX as of Q4 2022.
- Gofen & Glossberg held 2,970 shares of Vertex Pharmaceuticals worth $858K as of Q4 2022.
- Gofen & Glossberg bought 74 Vertex Pharmaceuticals shares in Q4 2022, an estimated $22.6K.
- Vertex Pharmaceuticals made up 0.02% of Gofen & Glossberg's portfolio in Q4 2022, its #262 holding.
- Gofen & Glossberg first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 39 quarters since.
- Gofen & Glossberg's Vertex Pharmaceuticals position peaked at $955K in Q2 2020.
- 1,223 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2022.
Based on Gofen & Glossberg's 13F filing for Q4 2022, filed 13 Jan 2023.